日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster.

首次人体 I 期试验,评估基于羊痘病毒的 COVID-19 疫苗加强针的安全性和免疫原性

Esen Meral, Fischer-Herr Johanna, Gabor Julian Justin, Gaile Johanna Marika, Fleischmann Wim Alexander, Smeenk Geerten Willem, de Moraes Roberta Allgayer, Bélard Sabine, Calle Carlos Lamsfus, Woldearegai Tamirat Gebru, Egger-Adam Diane, Haug Verena, Metz Carina, Reguzova Alena, Löffler Markus W, Balode Baiba, Matthies Lars C, Ramharter Michael, Amann Ralf, Kremsner Peter G

KCNC1-related disorders: new de novo variants expand the phenotypic spectrum

KCNC1相关疾病:新发现的从头变异扩展了表型谱

Park, Joohyun; Koko, Mahmoud; Hedrich, Ulrike B S; Hermann, Andreas; Cremer, Kirsten; Haberlandt, Edda; Grimmel, Mona; Alhaddad, Bader; Beck-Woedl, Stefanie; Harrer, Merle; Karall, Daniela; Kingelhoefer, Lisa; Tzschach, Andreas; Matthies, Lars C; Strom, Tim M; Ringelstein, Erich Bernd; Sturm, Marc; Engels, Hartmut; Wolff, Markus; Lerche, Holger; Haack, Tobias B